BioAge Labs (BIOA) Azelaprag Trial Halt Raises Questions About Pre-IPO Disclosure

San Francisco, California– (Newsfile Corp. – December 25, 2024) – On December 9, 2024, just a few months after making an initial public offering in September 2024, BioAge Labs, Inc.NADAQ: BIOA) made the surprise announcement that it is abandoning a…